title: Haemolytic uraemic syndrome during FK506 therapy.
authors.forename: T
authors.initials: T
authors.lastname: Ichihashi
authors.forename: T
authors.initials: T
authors.lastname: Naoe
authors.forename: H
authors.initials: H
authors.lastname: Yoshida
authors.forename: H
authors.initials: H
authors.lastname: Kiyoi
authors.forename: H
authors.initials: H
authors.lastname: Fukutani
authors.forename: K
authors.initials: K
authors.lastname: Kubo
authors.forename: T
authors.initials: T
authors.lastname: Yamauchi
authors.forename: H
authors.initials: H
authors.lastname: Saito
authors.forename: R
authors.initials: R
authors.lastname: Ohno
mesh_terms: D000328:Adult; D016026:Bone Marrow Transplantation; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy*; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D016559:Tacrolimus / Q000009:adverse effects*
chemical_list: D016559:Tacrolimus